Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replication

Although many drugs inhibit the replication of Epstein-Barr virus (EBV) in cell culture systems, there is still no drug that is effective and approved for use in primary EBV infection. More recently, maribavir (MBV), an l-ribofuranoside benzimidazole, has been shown to be a potent and nontoxic inhib...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wang, Fu-Zhang, Roy, Debasmita, Gershburg, Edward, Whitehurst, Christopher B., Dittmer, Dirk P., Pagano, Joseph S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2009
Konular:
Vaccines and Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786727/
https://ncbi.nlm.nih.gov/pubmed/19759127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01575-09
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller